Castle Biosciences Q2 2024 GAAP EPS $0.31 Beats $(0.28) Estimate, Sales $87.002M Beat $69.341M Estimate
Author: Benzinga Newsdesk | August 05, 2024 04:13pm
Castle Biosciences (NASDAQ:
CSTL) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.28) by 210.71 percent. The company reported quarterly sales of $87.002 million which beat the analyst consensus estimate of $69.341 million by 25.47 percent. This is a 73.53 percent increase over sales of $50.138 million the same period last year.
Posted In: CSTL